X4 Pharmaceuticals, Inc. (XFOR)
4.01
-0.03
(-0.74%)
USD |
NASDAQ |
Sep 01, 10:11
X4 Pharmaceuticals Cash from Operations (TTM) : -83.74M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -83.74M |
| March 31, 2026 | -92.85M |
| December 31, 2025 | -85.62M |
| September 30, 2025 | -103.09M |
| June 30, 2025 | -109.30M |
| March 31, 2025 | -109.67M |
| December 31, 2024 | -130.90M |
| September 30, 2024 | -125.65M |
| June 30, 2024 | -112.45M |
| March 31, 2024 | -103.60M |
| December 31, 2023 | -96.51M |
| September 30, 2023 | -87.86M |
| June 30, 2023 | -86.34M |
| March 31, 2023 | -83.38M |
| December 31, 2022 | -77.10M |
| September 30, 2022 | -77.06M |
| June 30, 2022 | -71.97M |
| March 31, 2022 | -72.69M |
| December 31, 2021 | -70.90M |
| September 30, 2021 | -69.36M |
| Date | Value |
|---|---|
| June 30, 2021 | -69.47M |
| March 31, 2021 | -61.74M |
| December 31, 2020 | -58.82M |
| September 30, 2020 | -50.56M |
| June 30, 2020 | -49.00M |
| March 31, 2020 | -51.83M |
| December 31, 2019 | -48.06M |
| September 30, 2019 | -45.55M |
| June 30, 2019 | -39.50M |
| March 31, 2019 | -30.99M |
| December 31, 2018 | -25.42M |
| September 30, 2018 | -31.59M |
| June 30, 2018 | -29.96M |
| March 31, 2018 | -30.54M |
| December 31, 2017 | -27.87M |
| September 30, 2017 | -18.13M |
| June 30, 2017 | -31.51M |
| March 31, 2017 | -19.10M |
| December 31, 2016 | -21.64M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | 93.95M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |
| Sangamo Therapeutics, Inc. | -90.34M |
| Anixa Biosciences, Inc. | -7.117M |